NCT05521347

Brief Summary

Purpose: investigators explored the effect of 3 mg/kg of caffeine supplementation on the cognitive ability and shooting performance of trained e-sports players. Methods: investigators recruited nine e-sports players who had received professional training in e-sports and had won at least eighth place in national-level e-sports shooting competitions. After performing three to five familiarization tests, investigators employed a randomized crossover design to divide participants into a caffeine trial (CAF) and a placebo trial (PL). The CAF group took capsules with 3 mg/kg of caffeine, whereas the PL group took a placebo capsule. After a 1-h rest, the Stroop task, visual search ability test, and the shooting ability test were conducted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 30, 2022

Completed
Last Updated

August 30, 2022

Status Verified

August 1, 2022

Enrollment Period

3 months

First QC Date

August 24, 2022

Last Update Submit

August 26, 2022

Conditions

Keywords

caffeinereaction time

Outcome Measures

Primary Outcomes (2)

  • Stroop task

    The color-word Stroop task and visual search test were conducted using Psych/Lab for Windows. The reaction time (millisecond) were recorded.

    1 hour after intervention

  • visual search test

    A total of 80 search displays were presented in 5 minutes. In each display, 5, 10, 15, or 20 -Tests were presented. The reaction time (millisecond) were recorded.

    1 hour after intervention

Secondary Outcomes (1)

  • aim trainer

    1 hour after intervention

Study Arms (2)

caffeine

EXPERIMENTAL

capsules with 3 mg/kg of caffeine

Behavioral: caffeine

placebo

PLACEBO COMPARATOR

The placebo capsule contained flour

Behavioral: caffeine

Interventions

caffeineBEHAVIORAL

we employed a randomized crossover design to divide participants into a caffeine trial (CAF) and a placebo trial (PL). The CAF group took capsules with 3 mg/kg of caffeine, whereas the PL group took a placebo capsule. After a 1-h rest, the Stroop task, visual search ability test, and the shooting ability test were conducted.

caffeineplacebo

Eligibility Criteria

Age20 Years - 50 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmale subjects
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • had experience with national competitions and regularly underwent training in first-person shooters

You may not qualify if:

  • no experience with national competitions and regularly underwent training in first-person shooters
  • have any diseases affecting the heart, bones, and joints or diseases that preclude exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University of Sport

Taichung, 404, Taiwan

Location

MeSH Terms

Interventions

Caffeine

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 24, 2022

First Posted

August 30, 2022

Study Start

January 1, 2022

Primary Completion

April 1, 2022

Study Completion

April 30, 2022

Last Updated

August 30, 2022

Record last verified: 2022-08

Locations